Know When to Offer COVID-19 Post-Exposure Prophylaxis
You’ll hear buzz about Regen-COV (casirivimab/imdevimab), the first med to PREVENT COVID-19...especially with cases on the rise.
This injectable monoclonal antibody combo blocks SARS-CoV-2 from entering cells.
It’s already authorized to TREAT mild to moderate COVID-19 in outpatients age 12 or older at high risk of severe illness. This includes patients with diabetes...age 65 or older...or even with a BMI over 25.